R ARIVANANTHAM
CHENNAI, DEC 20
City-based Geri Care, pioneers in Geriatric Care signed an MoU with the Mumbai-based tech-led oncology diagnostic major Karkinos Health Care to bring Non-Communicable Diseases (NCDs) and comprehensive cancer care solutions under one roof, to better serve the society at large.
After signing the MoU on Monday, Dr Lakshmipathy Ramesh, Founder & CEO and Dr V Srinivasan, Director & Co Founder, Geri Care said, “We are pleased to partner with Karkinos Healthcare as our diagnostics partner in India, for all oncology diagnostic tests that was not conducted in our own facilities thus far. We recognize the necessary skills, capabilities, and expertise that Karkinos Healthcare brings in the onco-care ecosystem, especially in the domain of molecular laboratory and next-gen cancer care solutions.”
- Partnership will enhance cancer care access, affordability and widen NCD care across TN: Dr Lakshmipathy Ramesh, Founder & CEO, Geri Care
- We also plan to expand the service to underprivileged senior citizens from our neighborhood: Dr. Rejiv Rajendranath, MD DM DNB, Clinical Lead, Geriatric Oncology Services, Geri Care Hospital
- We see this as the first phase of a long and wide-ranging partnership to transform the onco-care ecosystem in the region and beyond: R Venkataramanan, Founder and CEO, Karkinos Healthcare Pvt. Ltd
Dr. Rejiv Rajendranath, MD DM DNB, Clinical Lead, Geriatric Oncology Services, Geri Care Hospital said, “We understand and support the importance of early, preventive cancer screening amongst senior citizens, who are among the vulnerable segment of our society. We expect our partnership with Karkinos Healthcare will enhance the process and access to world-class cancer treatment at affordable cost. We also plan to expand the service to underprivileged senior citizens from our neighborhood. We are hopeful that this step helps in early detection and improve cure ratios of Cancer cases of Tamil Nadu and makes it a state with better wellness quotient.”
R Venkataramanan, Founder and CEO, Karkinos Healthcare Pvt. Ltd. said, “We are glad to announce our alliance with Geri Care, with its senior-citizen centric set up offering the entire range of Geriatric Healthcare services, a first in the country. This is an important partnership that will allow us an opportunity to work with a pool of well-qualified healthcare professionals and oncologists of various disciplines who are experienced in geriatric care treatment and patient care. We seek to provide support and enable community-centric healthcare camps with respect to NCD. The prime focus of Karkinos Healthcare is to create awareness and provide platform for the early detection of cancer in the country. We see this as the first phase of a long and wide-ranging partnership to transform the onco-care ecosystem in the region and beyond.”
This strategic partnership will lay the groundwork for systematic screening for common cancers in Chennai, with an end-to-end patient navigation support, access to Virtual Tumor Board (VTB) advisory services, opportunity to consult national and international oncology experts of eminence, eventually leading to next-gene sequencing and predictive analytics, which Karkinos Healthcare stands distinguished for.
Karkinos is pioneering the Distributed Cancer Care Network model in India addressing clinical needs of cancer patients, with a focus on early detection of cancer. The company works with multiple healthcare institutions and professionals in the oncology ecosystem, successfully bringing care closer to patients backed by a robust technology platform. Karkinos already offers its services in the states of Kerala, Karnataka, Andhra Pradesh, Telangana, Maharashtra, Madhya Pradesh, West Bengal, Manipur, Delhi NCR and now Tamil Nadu, and is planning to ramp up its operations across India.
Karkinos Health Care is a member of National Cancer Grid, a group of 260+ cancer focused institutions. It has partnered with leading institutions – IIT Bombay, IIT Guwahati, Cochin University of Science and Technology (CUSAT), and IIT Madras, to promote next generation research in cancer.
